Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Landos Biopharma, Inc. (LABP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
3
| Batycky Alka (Director) has filed a Form 3 on Landos Biopharma, Inc. |
| 09/07/2022 |
3
| Cataldi Fabio (Chief Medical Officer) has filed a Form 3 on Landos Biopharma, Inc. |
| 06/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/26/2022 |
3
| Truesdell Patrick (Vice President and Controller) has filed a Form 3 on Landos Biopharma, Inc. |
| 03/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/16/2021 |
3
| BITAR PATRICIA L (Interim CFO) has filed a Form 3 on Landos Biopharma, Inc. |
| 08/31/2021 |
3
| Callori Fred (Director) has filed a Form 3 on Landos Biopharma, Inc. |
| 05/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2021 |
3
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| WONG RODERICK (Director) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Poukalov Konstantin (10% Owner) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Hontecillas Raquel (Chief Scientific Officer) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Garabedian Christopher Nishan (Director) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Colombel Jean-Frederic (Director) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Chauhan Jyoti (ED, Global Clinical Operations) has filed a Form 3 on Landos Biopharma, Inc. |
| 02/03/2021 |
3
| Bassaganya-Riera Josep (Chairman, President and CEO) has filed a Form 3 on Landos Biopharma, Inc. |
|
|